Skip to Main Content
Thought Leadership

Deal Lawyers: Biotech Spin-Off Transactions

Read Time: 1 min

CONTRIBUTORS

Andrew Goodman

Partner, Mergers & Acquisitions

Daniel Nicholas

Partner, Tax

Seo Salimi

Partner, Capital Markets

Partners Andrew Goodman, Daniel Nicholas, Seo Salimi and Ziemowit Smulkowski discuss business reasons for biotech spin-offs, as well as spin-off considerations and planning, in this article published by Deal Lawyers.